Benzaldehydes react smoothly with the non-stabilized azome thine ylide derived from sarcosine and formaldehyde to form 5-aryloxazolidines as intermediates, which undergo ring-op ening to give N-benzyl-b-hydroxyphenethylamines in good yields by the action of arylmagnesium bromides. Their subsequent acid-catalyzed cyclization into 4-aryl-1,2,3,4-tetrahydroisoquinolines was performed in moderate to good yields.
1
Amaryllidac eae alkaloids such as cherylline (1) and latifine (2) have been isolated from Crinum latifolium and other Crinum species. 2 Nomifensine (3), a serotonin-norepinephrine-dopamine reuptake inhibitor, was marketed as an antidepress ant in the 1970-1980s. 3 Furthermor e, a large number of 4-aryltetr ahydroisoquinolines 4 and their hetero analogs 5 have been proposed as triple monoamine reuptake inhibitors , anti-ulce r and antihistamine drugs, for example, 4-(4-bromophenyl)-2-methyl-1,2,3,4-tetrahydroisoquinol ine (4) 6 (Fig. 1 ).
Due to the important applications of this class of compounds , their synthesis has been studied extensive ly. There are several routes for the preparation of 4-aryltetrahyd roisoquinolines , with most of them being complete d via the intramolecu lar cyclization of N-benzyl-b-hydroxyphene thylamines. [4] [5] [6] [7] The latter are obtained by the reaction of phenacyl bromides and benzylamines followed by a reduction step, 4a-d,6,7a or from styrene oxides and benzylamines. 7b,c In addition, there are a number of alternative methods based on Pictet-Spengl er cyclization of 2,2-diarylet hylamines, 8 the addition of lithium benzylamides to acetophenone enols, 9 direct deprotonation of C-4 in 1,2,3,4-tetra hydroisoqui nolines using sec-butyllithiu m, and subsequent arylation using aryl halides via aryne intermedi ates.
10
In connectio n with our interest in the development of azomethine yl id e ch emi st ry , 11 we ha ve de ve lo pe d a con ven ie nt , on e-po t me th od fo r th e pr ep ar ati on of 2-me thy l-1, 2,3 ,4 -t et ra hy dr oi so qu in oli n-4-o ls 5 fr om ar om at ic ald eh yd es be ari ng el ec tr on -d ona tin g su bs ti tu en ts and an azo me th in e yl id e de ri ve d fr om sa rc osi ne an d 
Contents lists available at SciVerse ScienceDi rect
Tetrahedro n Letters j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / t e t l e t fo rm al de hy de , vi a a no vel ar yl ox az ol id in e-te tra hy dr oi so qui no li ne re arr ang em en t. 12 In th is in tra mo le cu la r ele ct ro ph il ic su bs tit ut io n re act io n, in te rm ed ia te im in iu m cat io n A re ac ts wit h the nu cl eo ph il ic ar ene wi th fo rm at io n of the te tr ah yd ro is oqu in ol in e ri ng sy st em 5. Ta ki ng in to ac co unt th is re su lt , we en vi sa ge d th at th e ri ng -o pe ni ng of ox azo li di ne 6 by an ext er na l nu cl eo ph il ic ar ene wou ld pr od uce th e co rr es po nd in g N-b en zy l-b-h yd ro xy ph en eth yl ami ne, th e ke y in ter me di at e fo r ou r 4-ary l-1,2 ,3, 4-t et ra hy dr oi so qu in ol in e sy nt hesi s. To th e bes t of ou r kn ow le dg e, no su ch re ac ti on s ha ve be en re po rt ed to da te (Sc hem e 1).
We found that refluxing an aromatic aldehyde (1.0 mmol), sarcosine (1.5 mmol), and paraformald ehyde (3.0 mmol), in benzene or toluene for 6-8 h with azeotropic removal of water, allowed us to obtain 5-aryloxa zolidines 6 in high yields. 12, 13 The crude oily products were sufficiently pure according to the 1 H NMR spectra, and were used in the next stage without purification. Arylmagnesium bromides were prepared from aryl bromides (1.5 mmol) and magnesium (1.5 mmol) in THF according to the standard technique. To our delight, simple addition of oxazolidi ne 6 to a solution of the arylmagnesi um bromide resulted in full opening of cyclic aminal 6, and subsequent acidification led to the desired 2-(benzylmethylam ino)-1-arylethanols 7a-i (Scheme 2, Table 1 ).
14 The hydrochlori des of these compounds had different solubilities in water, so the best technique for their purification involved direct precipitatio n as a mixture with the magnesium salt from the THF-toluene solution, followed by washing to remove non-basic organic side products, and final basification of the salt mixture with concentrated aqueous NH 3 . Intramolecul ar cyclization of N-benzyl-b-hydroxyphene thylamines 7a-c was performed under previously described conditions (CH 2 Cl 2 , RT, H 2 SO 4 ; 6,7a-c for 7c-AlCl 3 4e,f ) to give 4-aryltetrahy droisoquinolin es 8a-c in moderate to good yields based on the starting aromatic aldehyde. Similarly, compounds 8d,e bearing an electron-donati ng methylened ioxy substituent on the aromatic ring were obtained in 37% and 39% yields, respectively. 15, 16 Application of this reaction to 2-thieny lmagnesium bromide led to a three-step synthesis of 4-(4-bromophenyl)-6-methy l-4,5,6,7-tetrahy drothieno[2,3-c]pyridine (8f) 17 in 65% yield, as a potential selective 5-HT reuptake inhibitor. 5c In this case, the cyclization step was performed under the action of PPA 7f,g (Scheme 2). It should be noted that the structure of thienopy ridine 8f needed additional confirmation because of the known possibility of isomeriz ation via a spirocyclic rearrangement. 7g This compound was thus identified by comparison of its 1 H NMR spectral data with those reported in the literature (the chemical shift of the H-3 thienyl proton at d 6.52 showing an upfield shift due to shielding by the phenyl ring). In a few cases (amino alcohols 7g-i), recognizable products could not be isolated, presumably due to the stabilizing effect of the p-alkoxy group on the initial benzylic carbocation intermediate, which makes cyclization difficult and facilitates intermolecu lar side reactions leading to the formatio n of resinous products. In the course of this study, N-benzyl-b-hydroxyp henethylamines 7c,e,f and 4-aryltetrahy droisoquinolin es 8e,f have been synthesized for the first time, while the other compounds were previously known. The results are compiled in Table 1 .
It is worth noting that compared with the previousl y known approaches for the synthesis of 4-aryl-1,2,3,4-tetrahydroisoqui nolines, the present method does not require the use of a reducing agent, and does not involve working with hazardous compounds , an inert atmosph ere, or chromatographi c purification of the intermediate liquid products, and thereby greatly facilitates the preparation of the target tetrahydroisoqui nolines.
In conclusion, we have develope d a new, three-step route to 4-aryl-1,2,3,4-tet rahydroisoq uinolines from aromatic aldehydes, sarcosine, and formaldehyd e via a 5-aryloxazolidi ne intermediate, followed by the reaction with an arylmagnes ium bromide and final acid-catalyzed cyclization. This method allows easy access to biologically important tetrahydroisoqui noline derivatives. Further application of this reaction for the construction of substituted tetrahydroisoq uinolines and their hetero analogs is underway in our laboratory and the results will be reported in due course.
